Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: France Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20021
20034
20046
20055
20068
20074
200817
200910
201017
20118
20127
20137
20146
20154
20163
20176
20181
20194
20201
20213
20223
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117
Terminated12
Recruiting6
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S40
Boehringer Ingelheim15
Sanofi15
AstraZeneca13
Eli Lilly and Company8
Hoffmann-La Roche7
Janssen Research & Development, LLC7
GlaxoSmithKline6
Lexicon Pharmaceuticals4
Novartis Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2137
Diabetes Mellitus47
Cardiovascular Diseases6
Glucose Metabolism Disorders5
Obesity5
Renal Insufficiency, Chronic5
Diabetic Nephropathies4
Kidney Diseases4
Metabolic Diseases4
Endocrine System Diseases3

Trials

Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.